Alan Horwich
Papers
3
Total Citations
2,937
H-Index
3
About
Alan Horwich is a leading figure in uro-oncology, with a career dedicated to advancing the diagnosis, treatment, and long-term management of genitourinary cancers. His primary research areas encompass renal cell carcinoma and prostate cancer, where he has made landmark contributions to clinical practice. Horwich is best known for authoring the ESMO Clinical Practice Guidelines for renal cell carcinoma, a seminal work that has amassed over 2,800 citations across its editions, including a 2014 version with 2,259 citations alone. These guidelines have become an indispensable resource for oncologists worldwide, standardizing care and improving patient outcomes. His 2013 guidelines for prostate cancer, with 164 citations, further underscore his influence in shaping evidence-based protocols. Beyond guideline authorship, Horwich’s impact is measured by his role in translating complex clinical trials into actionable strategies, bridging the gap between research and bedside practice. His work has not only guided treatment decisions but also inspired a generation of researchers to pursue rigorous, patient-centered studies in oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3